在急性和慢性髓性白血病中发现假定因果非编码RNA:全基因组门德尔随机化研究
Sunwoo Jung1, Ji-Won Kim2,3, Buhm Han1,4,5
1Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Korea.
Cancer research and treatment
|June 27, 2025
概括
这项研究揭示了非编码RNA (ncRNA) 和白血病之间的因果关系. 特定的ncRNAs,HCG22和RP11-42I10.1,与急性髓性白血病 (AML) 有关,而GMDS-AS1与慢性髓性白血病 (CML) 有关.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 非编码RNAs (ncRNAs) 越来越多地被认为是它们在癌症发展中的作用.
- 在急性髓性白血病 (AML) 和慢性髓性白血病 (CML) 中 ncRNAs 的特定因果关系需要进一步阐明.
研究的目的:
- 调查广泛的ncRNAs对发展AML和CML的风险的潜在因果影响.
- 为了确定可能在这些髓性白血病的发病过程中发挥直接作用的特定ncRNAs.
主要方法:
- 采用了一个全基因组,两样本的门德尔随机化 (MR) 研究设计.
- 利用来自大规模表达量化特征位点 (eQTL) 和全基因组关联研究 (GWAS) 的总结统计数据,包括FinnGen和英国生物银行.
- 采用通用反变量加权 (GIVW) 方法作为主要分析,支持MR-Egger,加权中位数和综合灵敏度分析以确保稳定性.
主要成果:
- 确定了高调 HCG22 和 RP11-42I10.1 与白血病风险增加之间的因果关系.
- 发现GMDS-AS1位点与CML风险增加之间存在积极联系.
- 结果在多种MR方法中一致,并在独立的数据集中验证,没有明显的偏见或混证据.
结论:
- 这项研究提供了强有力的证据,证明了特定的ncRNA和不同类型的髓性白血病之间的因果关系.
- 强调HCG22和RP11-42I10.1作为AML发展的潜在因果因素.
- 确定了GMDS-AS1位点作为CML病变发生的潜在因果因素.
更多相关视频
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.7K
相关概念视频
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
